Grape seed extract suppresses MDA-MB231 breast cancer cell migration and invasion

European Journal of Nutrition

Volumn 53, Issue 2, 2014, Pages 421-431

  Dinicola, Simona ^a   Pasqualato, Alessia ^a,b   Cucina, Alessandra ^a   Coluccia, Pierpaolo ^a   Ferranti, Francesca ^a,c   Canipari, Rita ^a   Catizone, Angela ^a   Proietti, Sara ^a   D'Anselmi, Fabrizio ^d   Ricci, Giulia ^e   Palombo, Alessandro ^a   Bizzarri, Mariano ^d,f  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c ITALIAN SPACE AGENCY   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f NONE   (Italy)

Author keywords

Breast cancer; GSE; Invasion; Metalloproteinases

Indexed keywords

BETA CATENIN; FASCIN; GELATINASE A; GELATINASE B; GRAPE SEED EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UROKINASE;

APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL STIMULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; GELATIN ZYMOGRAPHY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING; ZYMOGRAPHY;

VITACEAE;

APOPTOSIS; BETA CATENIN; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GRAPE SEED EXTRACT; HUMANS; MATRIX METALLOPROTEINASES; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; NF-KAPPA B; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84896691571     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0542-6     Document Type: Article

References (48)

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
2. Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895-904
3. Bogenrieder T, Herlyn M (2003) Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22:6524-6536
4. Jezierska A, Motyl T (2009) Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit 15:RA32-RA40
5. Alexander CM, Werb Z (1991) Extracellular matrix degradation. Plenum Press, New York, pp 255-302
6. Mignatti P, Rifkin DB (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161-195
7. Danø K, Andreasen PA, Grøndahl-Hansen J et al (1985) Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266
8. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52-67
9. Lin KL, Tsai PC, Hsieh CY et al (2011) Antimetastatic effect and mechanism of ovatodiolide in MDA-MB-231 human breast cancer cells. Chem Biol Interact 194:148-158
10. Jiang P, Enomoto A, Takahashi M (2009) Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett 284:122-130
11. Vignjevic D, Kojima S, Aratyn Y et al (2006) Role of fascin in filopodial protrusion. J Cell Biol 174:863-875
12. Edwards RA, Bryan J (1995) Fascins, a family of actin bundling proteins. Cell Motil Cytoskelet 32:1-9
13. Vignjevic D, Schoumacher M, Gavert N et al (2007) Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 67:6844-6853
14. Brabletz T, Jung A, Hermann K et al (1998) Nuclear overexpression of the oncoprotein β-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 194:701-704
15. Gavert N, Conacci-Sorrell M, Gast D et al (2005) L1, a novel target of h-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 168:633-642
16. Al-Alwan M, Olabi S, Ghebeh H et al (2011) Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules. PLoS One 6:e27339
17. Westermarck J, Kähäri VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781-792
18. Lokeshwar BL (1999) MMP inhibition in prostate cancer. Ann NY Acad Sci 878:271-289
19. Brawley OW, Barnes S, Parnes H (2001) The future of prostate cancer prevention. Ann NY Acad Sci 952:145-152
20. Palmer S (1985) Diet, nutrition, and cancer. Prog Food Nutr Sci 9:283-341
21. Dinicola S, Cucina A, Pasqualato A et al (2010) Apoptosis-inducing factor and caspase-dependent apoptotic pathways triggered by different grape seed extracts on human colon cancer cell line Caco-2. Br J Nutr 104:824-832
22. Dinicola S, Cucina A, Pasqualato A et al (2012) Antiproliferative and apoptotic effects triggered by grape seed extract (GSE) versus epigallocatechin and procyanidins on colon cancer cell lines. Int J Mol Sci 13:651-664
23. Dinicola S, Mariggiò MA, Morabito C et al (2013) Grape seed extract triggers apoptosis in Caco-2 human colon cancer cells through reactive oxygen species and calcium increase: extracellular signal-regulated kinase involvement. Br J Nutr. doi: 10.1017/S0007114512006095
24. Sharma G, Tyagi AK, Singh RP et al (2004) Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells. Breast Cancer Res Treat 85:1-12
25. Cavaliere C, Foglia P, Gubbiotti R et al (2008) Rapid-resolution liquid chromatography/mass spectrometry for determination and quantitation of polyphenols in grape berries. Rapid Commun Mass Spectrom 22:3089-3099
26. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
27. Belin D, Godeau F, Vassalli JD (1984) Tumor promoter PMA stimulates the synthesis and secretion of mouse pro-urokinase in MSV-transformed 3T3 cells: this is mediated by an increase in urokinase mRNA content. EMBO J 3:1901-1906
28. Nandakumar V, Singh T, Katiyar SK (2008) Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 269:378-387
29. Joshi SS, Kuszynski CA, Bagchi D (2001) The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract. Curr Pharm Biotechnol 2:187-200
30. Saeki K, Hayakawa S, Isemura M et al (2000) Importance of a pyrogallol-type structure in catechin compounds for apoptosis-inducing activity. Phytochemistry 53:391-394
31. Wu PP, Kuo SC, Huang WW et al (2009) (-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway. Anticancer Res 29:1435-1442
32. Ling H, Zhang Y, Ng KY et al (2011) Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res Treat 126:609-620
33. Ko HS, Lee HJ, Kim SH et al (2012) Piceatannol suppresses breast cancer cell invasion through the Inhibition of MMP-9: involvement of PI3K/AKT and NF-κB Pathways. J Agric Food Chem 60:4083-4089
34. Kim S, Han J, Lee SK et al (2011) Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells. J Surg Res 176:21-29
35. Vayalil PK, Mittal A, Katiyar SK (2004) Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NF kappa B. Carcinogenesis 25:987-995
36. Vayalil PK, Katiyar SK (2004) Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells. Prostate 59:33-42
37. Duffy MJ, Maguire TM, Hill A et al (2000) Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2:252-257
38. Zucker S, Hymowitz M, Conner C et al (1999) Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann NY Acad Sci 878:212-227
39. Yang SF, Chen MK, Hsieh YS et al (2010) Antimetastatic effects of Terminalia catappa L. on oral cancer via a down-regulation of metastasis-associated proteases. Food Chem Toxicol 48:1052-1058
40. Aguirre Ghiso JA, Alonso DF, Farías EF et al (1999) Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur J Biochem 263:295-304
41. Sliva D (2004) Signaling pathways responsible for cancer cell invasion as targets for cancer therapy. Curr Cancer Drug Targets 4:327-336
42. Takada Y, Singh S, Aggarwal BB (2004) Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis. J Biol Chem 279:15096-15104
43. Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6:203-208
44. Snyder M, Huang XY, Zhang JJ (2011) Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration. J Biol Chem 286:38886-38893
45. Adams JC (2004) Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 16:590-596
46. Machesky LM, Li A (2010) Fascin: invasive filopodia promoting metastasis. Commun Integr Biol 3:263-270
47. Jamieson C, Sharma M, Henderson BR (2012) Wnt signaling from membrane to nucleus: β-catenin caught in a loop. Int J Biochem Cell Biol 44:847-850
48. Valenta T, Hausmann G, Basler K (2012) The many faces and functions of β-catenin. EMBO J 31:2714-2736